NCT07333534 Hard Tissue Augmentation With or Without Connective Tissue Graft in Immediate Esthetic Implants
| NCT ID | NCT07333534 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Baghdad |
| Condition | Dental Implant |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2025-12-20 |
| Primary Completion | 2026-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2025-12-20 with a primary completion date of 2026-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This randomized controlled study is aimed to evaluate the esthetic, clinical, and radiographic outcomes following the placement of immediate single-tooth implant with hard and soft tissue augmentation. Subjects will randomly assigned to one of two groups: * Group A (control group) receiving an immediate single-tooth implant in the esthetic zone with bone augmentation only. * Group B (study group) receiving an immediate single-tooth implant in the esthetic zone with bone augmentation and connective tissue graft (CTG). The main questions it aims to answer is: Is there is a significant difference in the esthetic outcome between bone augmentation alone and bone augmentation combined with connective tissue graft after immediate dental implant in the esthetic zone?
Eligibility Criteria
Inclusion Criteria: * Patients with a non-restorable tooth or a remaining root without signs of acute infection in the maxillary esthetic zone. * The failing tooth is an incisor, canine or first bicuspid in the maxilla bounded by natural sound teeth. * Sufficient bone (\>4 mm) apically and palatally to allow for proper implant positioning with sufficient primary stability (≥35 N cm). * Sufficient mesial-distal and interocclusal space for placement of the implant and definitive restoration. Exclusion Criteria: * Patients with systemic conditions affecting bone healing (e.g., uncontrolled diabetes). * Teeth with current acute periapical infection. * Dehiscence of the labial (facial) bone plate after extraction. * Signs of uncontrolled periodontal disease. * Heavy smokers and vulnerable groups (pregnant females and decision-impaired individuals). * History of head and neck radiation therapy.
Contact & Investigator
Khalid Khalid, Bachelor of Dental Surgery
✉ khaled.waleed2408m@codental.uobaghdad.edu.iq📞 +9647716641706
Frequently Asked Questions
Who can join the NCT07333534 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Dental Implant. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07333534 currently recruiting?
Yes, NCT07333534 is actively recruiting participants. Contact the research team at khaled.waleed2408m@codental.uobaghdad.edu.iq for enrollment information.
Where is the NCT07333534 trial being conducted?
This trial is being conducted at Baghdad, Iraq.
Who is sponsoring the NCT07333534 clinical trial?
NCT07333534 is sponsored by University of Baghdad. The trial plans to enroll 28 participants.